c-erbB2 is best known in its role in breast cancer, where it is amplified in approximately 20% of invasive cancers. The humanized monoclonal antibody, trastuzumab, and the small molecule, lapatinib, inhibit c-erbB2.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Regulatory Status |
RUO – Research Use Only |
---|